CAPTIS DIAGNOSTICS

State College, PA · Medtech · Private

Liquid biopsy assay using lipid nanoprobes and long-read sequencing to detect NTRK gene fusions in circulating extracellular vesicles from blood plasma

Grants
$4.0M
9 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$355K
1 award · Health and Human S
#408 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Develop a rapid, efficient and low cost extracellular vesicles isolation method toward non-invasive non-small cell lung cancer molecular analysis$357,000
Federal grantDepartment of Health and Human Services · Phase I · An ultrasensitive virus identification method for acute respiratory virus infections using carbon nanotube arrays-integrated microdevice$300,000
Federal grantDepartment of Health and Human Services · Phase I · Develop a rapid, efficient and low cost extracellular vesicles isolation method toward non-invasive non-small cell lung cancer molecular analysis$55,000
Federal grantDepartment of Health and Human Services · Phase I · Develop a rapid, efficient and low cost extracellular vesicles isolation method toward non-invasive non-small cell lung cancer molecular analysis$2,000
Federal contractDepartment of Health and Human Services · Captis Diagnostics - SBIR Concept Award - Development Of Non-invasive Assay For Molecular Characterization Of Pediatric Low-grade Glioma$354,637
Federal grantDepartment of Health and Human Services · Phase I · Non-invasive detection of tumor NTRK gene fusions via rapid, efficient and low-cost extracellular vesicle isolation method$400,000
Federal grantDepartment of Health and Human Services · Phase I · A nanosized magnetic particle system for fast and efficient neuronal extracellular vesicle enrichment from plasma$306,509
Federal grantDepartment of Health and Human Services · Phase II · Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids$1,077,369
Federal grantDepartment of Health and Human Services · Phase II · Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids$1,117,056
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
405DXRAY, INC.$378K—
406RESHAPE LIFESCIENCES INC$374K$114M
407CELLFE INC$359K—
408CAPTIS DIAGNOSTICS$355K—
409C-MOTION, INC.$350K—
410Stereology Resource Center, Inc.$349K—
411Healthtech Solutions, Inc.$338K$50K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.